Status:
COMPLETED
Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA)
Lead Sponsor:
Butantan Institute
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
This is an observational study, meaning that no interventions is tested, to determine incidence of SARS-CoV-2 infection and COVID-19 in different clinical sites in Brazil in several age groups. The st...
Detailed Description
This is an observational longitudinal study to assess incidence of SARS-CoV-2 infection in Brazil. The study sample is stratified in nine age groups according decades of life, equally distributed in b...
Eligibility Criteria
Inclusion
- Any sex or age
- Providing informed consent
- Agreement with all study visits, procedure and contacts
Exclusion
- Previous suspected or confirmed COVID-19
- Febrile illness in the latest 72 hours
- Olfactory or gustatory dysfunction in the last three months
- Healthcare worker in a service with routine attention to COVID-19 patients
- Any conditions that can might hurdle participant's compliance to the study in tha opinion of the study team
Key Trial Info
Start Date :
October 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
3520 Patients enrolled
Trial Details
Trial ID
NCT04355338
Start Date
October 25 2020
End Date
October 30 2024
Last Update
February 6 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal do Ceará
Fortaleza, Ceará, Brazil, 60430-160
2
Universidade de Brasília
Brasília, Federal District, Brazil, 71691-082
3
Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil, 30750-140
4
Hospital Universitário Júlio Müller da Universidade Federal de Mato Grosso
Cuiabá, Mount, Brazil, 78048-610